scholarly journals Ovarian blood flow in healthy women and patients with ovarian failure

2005 ◽  
Vol 54 (5S) ◽  
pp. 50-51
Author(s):  
L. K. Dzhemlikhanova ◽  
E. N. Popov

Objective: to investigate the relationships between ovarian blood flow, folliculogenesis and sex-steroids production during normal menstrual cycle and in women with ovarian failure

2021 ◽  
Vol 50 (4) ◽  
pp. 52-57
Author(s):  
L. X. Dzhemlikhanova ◽  
M. N. Bogdanova ◽  
I. Yu. Kogan

The aim of this study was to investigate the relation between ovarian blood flow, folliculogenesis and sex-steroid production during normal menstrual cycle and in women with ovarian failure. Ten healthy women and 40 patients with ovarian failure underwent hormonal assays (follicle-stimulating, luteinizing hormones, estradiol, progesterone, prolactine, testosterone) and ultrasound examination of the uterus and ovaries with color Doppler ultrasonography of the uterine and ovarian vessels on the 3 -5th, 11- 13th, 17- 19th and 21 -23rd days оf menstrual cycle. Intraovarian blood flow of the ovary carrying the predominant follicle in healthy women appeared more active than in conrdlateral ovary on the 3-5th days of the cycle. Inpatients with ovarian failure no difference was detected between the ovaries during the periods in question. Ovarian and uterine blood flow inpatients with the ovarian failure was less intensive comparingwith healthy women. Positive correlation between uterine blood flow and estradiol concentration in serum was revealed.


2013 ◽  
Vol 44 (1) ◽  
pp. 103-112
Author(s):  
Ayten Oguz ◽  
Mehmet Gumus ◽  
Ali Ipek ◽  
Dilek Tuzun ◽  
Reyhan Ersoy ◽  
...  

2001 ◽  
Vol 9 (2) ◽  
pp. 153-171 ◽  
Author(s):  
M Hickey ◽  
IS Fraser

The term breakthrough bleeding (BTB) is rather poorly defined, but essentially describes the symptom of vaginal bleeding occurring with scheduled periods of withdrawal bleeding, in the absence of pelvic pathology in women taking exogenous sex steroids, usually contraceptives or hormone-replacement therapy (HRT). It may also describe occasional bleeding in those who are predominantly experiencing amenorrhoea due to these preparations. Rather confusingly, the term is sometimes used to describe intermenstrual bleeding in women who are not taking sex steroids, when structural or other pathological causes are more likely. In the absence of such pathology intermenstrual bleeding in the normal menstrual cycle is relatively uncommon, suggesting that exogenous sex steroids can profoundly disrupt the tight regulation of endometrial vascular development, function and breakdown. Intermenstrual bleeding also occurs spontaneously in some women and it is possible that this phenomenon has similar mechanisms to that seen in sex-steroid-related breakthrough bleeding.


1998 ◽  
Vol 24 (1) ◽  
pp. 15-20 ◽  
Author(s):  
Suk-Tak Chan ◽  
Fiona Brook ◽  
Anil Ahuja ◽  
Brian Brown ◽  
Constantine Metreweli

Sign in / Sign up

Export Citation Format

Share Document